South Africa Cardiovascular Devices Market Size (2024 - 2029)

South Africa Cardiovascular Devices Market Analysis

The South African cardiovascular device market is poised to grow at a CAGR of 6% during the forecast period.

The COVID-19 pandemic affected the manufacturing of cardiovascular devices. The decrease in cardiovascular disease diagnoses due to healthcare resources allocated to COVID-19 patients had a detrimental influence on the market. According to the study published in Global Heart in March 2021, about 19% of hospitalized cases had evidence of cardiac injury. SARS-COV was associated with cardiomyopathy. Other cardiovascular findings include hypotension, arrhythmias, and sudden death. Persistent tachycardia was the most typical arrhythmia found in 72% of cases that persisted for weeks in COVID-19 patients. Thus, the cardiac disease market was significantly impacted during the pandemic as the number of cardiac incidences increased with COVID-19. However, the market has recovered well since the limitations were relaxed. The market recovery over the previous two years has been led by the increasing prevalence of heart illnesses and new product introductions.

The market is driven by the rising burden of cardiovascular diseases, technological advancement in cardiovascular devices, and increased awareness about cardiac diseases and treatment. The increasing burden of various coronary heart disorders, including cardiomyopathy and stroke, which account for most deaths from cardiac causes, is also driving the market. Cardiovascular diseases, the leading causes of death in South Africa, are the most prevalent ailments identified among the population. According to a study published in the Cardiovascular Journal of Africa in May 2021, every hour, five people have suffered from a stroke, and ten people suffered a heart attack. Additionally, obesity is a risk factor for CVD, and the growing prevalence of obesity will propel market growth. According to the study published in BMJ Open Journal in February 2022, adults without private health insurance in South Africa have hypertension in about 8.22 million cases annually. According to estimates, hypertension contributes to 6,100 new cases of chronic renal and, 14,000 cases of ischemic heart disease annually, and 13,300 strokes. Thus, the growing prevalence of cardiovascular diseases will propel market growth.

Furthermore, various initiatives launched by the government and private organizations in the country are expected to boost the market. In March 2022, WHF (World Hewart Federation) organized a site visit to Maputo, Mozambique, as part of the Colours to Save Hearts program. The WHF initiative Colors to Save Hearts, which is run by the Mozambique Institute for Health Education and Research and implemented by the National Health Institute of Mozambique (INS), aims to educate parents, teachers, and kids about the connection between rheumatic heart disease (RHD) and sore throats. They also shared how to recognize the symptoms of RHD and what to do when they first appear.

Thus, all factors mentioned above, such rising prevalence of cardiac diseases and government initiatives, are expected to boost the market in the country over the forecast period. However, a stringent regulatory scenario is expected to restrain the market growth over the forecast period.

South Africa Cardiovascular Devices Industry Segmentation

As per the scope of the report, cardiovascular devices are for diagnosing heart diseases and treating related health problems. The South Africa Cardiovascular Devices Market is segmented by device type (diagnostic and monitoring devices (Electrocardiogram (ECG), remote cardiac monitoring, and other diagnostic and monitoring devices), and therapeutic and surgical devices (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, Grafts, Heart Valves, Stents, Other Therapeutic and Surgical Devices). The report offers the value in ( USD million) for all the above segments.